Berger A, Sadosky A, Edelsberg J, Dukes E, Martin SA, Oster G. Characteristics and patterns of healthcare utilization of patients with fibromyalgia in general practitioner settings in Germany. Curr Med Res Opin. 2008 Sep;24(9):2489-99.
Menzin J, Wygant G, Hauch O, Jackel JL, Friedman M. One-year costs of ischemic heart disease among patients with acute coronary syndromes: findings from a multi-employer claims database. Curr Med Res Opin. 2008 Feb;24(2):461-8. doi: 10.1185/030079908X261096 .
Beard SM, McCrink L, Le TK, Garcia-Cebrian A, Monz B, Malik RA. Cost effectiveness of duloxetine in the treatment of diabetic peripheral neuropathic pain in the UK. Curr Med Res Opin. 2008 Feb;24(2):385-99.
Earnshaw SR, Graham CN, Ettinger B, Amonkar MM, Lynch NO, Middelhoven H. Cost-effectiveness of bisphosphonate therapies for women with postmenopausal osteoporosis: implications of improved persistence with less frequently administered oral bisphosphonates. Curr Med Res Opin. 2007 Oct 1;23(10):2517-29.
Yood MU, Lafata JE, Koro C, Wells KE, Pladevall-Vila M. Time to pharmacotherapy change in response to elevated HbA(1c) test results. Curr Med Res Opin. 2006 Aug;22(8):1567-74.
Portenoy R, ID Pain Steering Committee, McLeod LD. Development and testing of a neuropathic pain screening questionnaire: ID Pain. Curr Med Res Opin. 2006;22(8):1555-65.
Mladsi DM, Grogg AL, Irish WD, Lopez RB, Degen K, Swann A, Nimsch CT. Pharmacy cost evaluation of risperidone, olanzapine, and quetiapine for the treatment of schizophrenia in acute care inpatient settings. Curr Med Res Opin. 2004 Jan 1;20(12):1883-93. doi: 10.1185/030079904X11510.
Anthony MS, Clarkson TB. Does extent of pretreatment atherosclerosis influence the effects of conjugated equine estrogens on atherosclerosis progression? Presented at the 51st Annual Scientific Session of the American College of Cardiology; March 17, 2002. Atlanta, GA. [abstract] J Am Coll Cardiol. 2002 Mar; 39:248A.
Palka P, Lange A, Fleming AD, Donnelly JE, Dutka DP, Starkey IR, Shaw TR, Sutherland GR, Fox KA. Differences in myocardial velocity gradient measured throughout the cardiac cycle in patients with hypertrophic cardiomyopathy, athletes and patients with left ventricular hypertrophy due to hypertension. J Am Coll Cardiol. 1997 Sep 1;30(3):760-8. doi: 10.1016/s0735-1097(97)00231-3
Palka P, Lange A, Fleming AD, Fenn LN, Shaw TRD, Starkey IR, Fox KAA, McDicken WN, Sutherland GR. Assessment of transmural velocity gradients in hypertrophic hearts-A new diagnostic index for hypetrophic cardiomyopathy. J Am Coll Cardiol. 1996 Feb 1;27(2_supplement_1):21.